GFM
MRVI icon

GF Fund Management’s Maravai LifeSciences MRVI Stock Holding History

GF Fund Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.17K Buy
3,241
+392
+14% +$1.33K ﹤0.01% 566
2025
Q4 		$9.26K Sell
2,849
-264
-8% -$889 ﹤0.01% 581
2025
Q3 		$8.93K Sell
3,113
-518
-14% -$1.32K ﹤0.01% 562
2025
Q2 		$8.75K Hold
3,631
– – ﹤0.01% 583
2025
Q1 		$8.03K Buy
3,631
+653
+22% +$2.58K ﹤0.01% 586
2024
Q4 		$16.2K Buy
+2,978
New +$19.2K ﹤0.01% 490

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GF Fund Management's MRVI Position: Q1 2026 in Review

GF Fund Management increased its Maravai LifeSciences (MRVI) stake by 14% in Q1 2026, buying an estimated $1.33K and bringing the position to 3,241 shares worth $9.17K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

GF Fund Management first reported a position in MRVI in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.2K in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • GF Fund Management held 3,241 shares of Maravai LifeSciences worth $9.17K as of Q1 2026.
  • GF Fund Management bought 392 Maravai LifeSciences shares in Q1 2026, an estimated $1.33K.
  • Maravai LifeSciences made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #566 holding.
  • GF Fund Management first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Maravai LifeSciences position peaked at $16.2K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.